Ovarian activity in women taking an oral contraceptive containing 20 μg ethinyl estradiol and 150 μg desogestrel: Effects of low estrogen doses during the hormone-free interval

American Journal of Obstetrics and Gynecology

Volumn 179, Issue 1, 1998, Pages

  Killick, S R ^a   Fitzgerald, C ^a   Davis, A ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

Desogestrel; Folliculogenesis; Mircette(TM); Oral contraception; Ovarian suppression

Indexed keywords

DESOGESTREL; DESOGESTREL PLUS ETHINYLESTRADIOL; ESTRADIOL; ETHINYLESTRADIOL; LOW DOSE ORAL CONTRACEPTIVE; PLACEBO; PROGESTERONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MIXTURE; FEMALE; HUMAN; HUMAN EXPERIMENT; LUTEINIZATION; NORMAL HUMAN; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; OVARY CYCLE; OVARY FOLLICLE; OVARY FUNCTION; OVULATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031856034     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(98)70292-3     Document Type: Article

References (15)

1. U. Lachnit-Fixon Development and clinical evaluation of triphasic oral contraception M Elstein Update on triphasic oral contraception. 1982 Excerpta Medica Amsterdam 37 53
2. K Fotherby ADS. Caldwell New progestogens in oral contraception Contraception 49 1994 1 32
3. K Fotherby ADS. Caldwell Review: the new low dose oral contraceptives J Obstet Gynaecol 14 1994 327 332
4. M Mall-Häfeli I Werner-Zodrow PR Huber A Edelman Oral contraception and ovarian function B Runnebaum T Rabe L Kiesel Female contraception 1988 Springer-Verlag Berlin 97 105
5. C Fitzgerald W Feichtinger J Spona M Elstein F Lüdicke U Müller A comparison of the effects of two monophasic low dose oral contraceptives on the inhibition of ovulation Adv Contracept 10 1994 5 18
6. J Spona M Elstein W Feichtinger H Sullivan F Lüdicke U Müller Shorter hormone-free interval in combined oral contraceptives decreases follicular development Contraception 54 1996 1 77
7. M Elstein PG Briston M Jenkins D Kirk H. Miller Effects of a low-oestrogen oral contraceptive on urinary excretion of luteinizing hormone and ovarian steroids BMJ 1 1974 11 13
8. PG Crossignani G Testa W Vegetti F. Parazzini Ovarian activity during regular contraceptive use Contraception 54 1996 271 273
9. B Hedon P Cristol A Plauchut AM Vallon F Desachampts ML Taillant Ovarian consequence of the transient interruption of combined oral contraceptives Int J Fertil 27 suppl 3 1992 162 168
10. SR. Killick Ovarian follicles during oral contraceptive cycles: their potential for ovulation Fertil Steril 52 1989 580 582
11. L Speroff RM Glass NG Kinse Clinical gynecologic endocrinology and infertility. 5th ed 1994 Williams & Wilkins Philadelphia 739 740
12. ZM van der Spuy U Sohnius CA Pienaar R. Schall Gonadotropin and estradiol secretion during the week of placebo therapy in oral contraceptive pill users Contraception 42 1990 597 609
13. BCJM Fauser AM. Van Heusden Manipulation of human ovarian function: physiological concepts and clinical consequences Endocrine Rev 18 1997 71 106
14. MJ Rosenberg SC. Long Oral contraceptives and cycle control: a critical review of the literature Adv Contracept 8 suppl 1 1992 35 45
15. The Mircette™ Study Group An open label multicenter noncomparative safety and efficacy study of the desogestrel-containing oral contraceptive Mircette™ Am J Obstet Gynecol 179 1998 S2 S8